Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

News > All

Total search results: 12043 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. 2019-09-17
Procarta Biosystems Ltd.. (9/17/19). "Press Release: Procarta Receives CARB-X Award of up to $9.2 million". Stevenage. 2019-09-17
Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. 2019-09-16
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2019-09-16
PPF Group N.V.. (9/16/19). "Press Release: PPF Expands Its Investment in the Healthcare Sector through Acquisition of Significant Stake in T Cell Therapy Company Autolus Therapeutics". 2019-09-16
H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA. 2019-09-16
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. 2019-09-12
SpringWorks Therapeutics, Inc.. (9/12/19). "Press Release: SpringWorks Therapeutics Announces Pricing Of Initial Public Offering". Stamford, CT. 2019-09-12
Healthy.io Ltd.. (9/12/19). "Press Release: Healthy.io Raises $60 Million in Series C Funding and Receives FDA Clearance for Smartphone-Based Test to Diagnose Chronic Kidney Disease". Tel Aviv. 2019-09-12
10x Genomics Inc.. (9/12/19). "Press Release: 10x Genomics Announces Pricing of Initial Public Offering". Pleasanton, CA. 2019-09-12
UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA. 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Atomwise Announces Largest China-US Collaboration for AI Drug Discovery". San Francisco, CA. 2019-09-11
Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. 2019-09-10
Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam. 2019-09-10
Insilico Medicine. (9/10/19). "Press Release: Insilico Medicine Secures $37m in Series B Funding Led by Qiming Venture Partners". Hong Kong. 2019-09-10
BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. 2019-09-09
Cerevel Therapeutics, LLC. (9/9/19). "Press Release: Cerevel Therapeutics Appoints Biotechnology Leader Tony Coles, M.D., as Chief Executive Officer". Boston, MA. 2019-09-09
Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. 2019-09-09
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
Eli Lilly and Company. (9/9/19). "Press Release: Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Canc 2019-09-09
Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. 2019-09-09
Invitae Corporation. (9/6/19). "Press Release: Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes". San Francisco, CA. 2019-09-06
Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel. 2019-09-06
ADC Therapeutics S.A.. (9/6/19). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. 2019-09-06
Crain Communications Inc.. (9/6/19). "Press Release: Crain Communications Inc Acquires Online News Organization GenomeWeb". Detroit, MI. 2019-09-06
Uniqure N.V.. (9/5/19). "Press Release: Uniqure Announces Pricing of its Public Offering". Lexington, MA & Amsterdam. 2019-09-05
Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to 2019-09-05
Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. 2019-09-05
Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London. 2019-09-05
BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz. 2019-09-04
Fulcrum Therapeutics, Inc.. (9/4/19). "Press Release: Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team". Cambridge, MA. 2019-09-04
Uniqure N.V.. (9/4/19). "Press Release: Uniqure Announces Proposed Public Offering". Lexington, MA & Amsterdam. 2019-09-04
Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. 2019-09-04
Inotrem S.A.. (9/3/19). "Press Release: Inotrem Announces Fast Track Designation Granted by U.S. FDA to Nangibotide Development Program for the Treatment of Septic Shock". Paris. 2019-09-03
Uniqure N.V.. (9/3/19). "Press Release: Uniqure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-09-03
Roche. (9/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-09-03
Evonik Industries AG. (9/3/19). "Press Release: Evonik Acquires a Surface Modification Technology Platform from Interface Biologics to Further Expand Its Medical Device Capabilities". 2019-09-03
Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. 2019-09-03
Achilles Therapeutics. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. 2019-09-03
Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. 2019-09-02
Tecan Group Ltd.. (8/30/19). "Press Release: Tania Micki to Succeed Long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 Annual Financial Statements". Männedorf. 2019-08-30
Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne. 2019-08-30
Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. 2019-08-30
AbbVie Inc.. (8/29/19). "Press Release: AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program". North Chicago, IL. 2019-08-29
Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. 2019-08-29
Roche. (8/29/19). "Press Release: Roche Launches Ventana PD-L1 (SP142) Assay in CE Markets as First Companion Diagnostic to Identify Triple-negative Breast Cancer Patients Eligible for Treatment with Tecentriq". Basel. 2019-08-29
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). 2019-08-29
Waters Corporation. (8/28/19). "Press Release: Waters Corporation Names Jonathan M. Pratt as President of TA Instruments". Milford, MA. 2019-08-28
Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. 2019-08-28
Sanofi S.A.. (8/28/19). "Press Release: U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9". Paris & Tarrytown, NY. 2019-08-28
Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen. 2019-08-28
Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. 2019-08-28
HiFiBio Therapeutics. (8/28/19). "Press Release: HiFiBio Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders". Cambridge, MA, Shanghai & Paris. 2019-08-28
Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen. 2019-08-28
Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire. 2019-08-27
Abionyx Pharma S.A.. (8/27/19). "Press Release: Change of Name and Stock Symbol/Mnemonic of Abionyx Pharma Shares (formerly Cerenis Therapeutics) as of August 29, 2019". Toulouse & Lakeland, US. 2019-08-27
Coriell Life Sciences. (8/27/19). "Press Release: KPMG, Coriell Life Sciences and Thermo Fisher Scientific to Collaborate on Links between Medications and Genes". New York, NY & Philadelphia, PA. 2019-08-27
Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. 2019-08-27
Agilent Technologies Inc.. (8/26/19). "Press Release: Agilent Completes Acquisition of BioTek Instruments". Santa Clara, CA. 2019-08-26
Atonarp Inc.. (8/26/19). "Press Release: Atonarp Inc. Announces $33 Million Series C Funding Round Completion". Tokyo. 2019-08-26
ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. 2019-08-26
Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. 2019-08-26
Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. 2019-08-25
HotSpot Therapeutics, Inc.. (8/23/19). "Press Release: HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc.". Boston, MA. 2019-08-23
Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen. 2019-08-23
GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. 2019-08-23
Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. 2019-08-23
MDClone Ltd.. (8/22/19). "Press Release: MDClone, Developer of First Healthcare Synthetic Data Engine, Raises $26 Million". Beer-Sheva. 2019-08-22
GlaxoSmithKline plc. (8/22/19). "Press Release: ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered every Two Months". London. 2019-08-22
Finch Therapeutics Group, Inc.. (8/22/19). "Press Release: Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas". Somerville, MA. 2019-08-22
AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". 2019-08-22
Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. 2019-08-22
AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". 2019-08-22
Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. 2019-08-21
PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA. 2019-08-21
Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. 2019-08-20
Genomenon, Inc.. (8/20/19). "Press Release: Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market". Ann Arbor, MI. 2019-08-20
Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. 2019-08-20
Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. 2019-08-20
Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. 2019-08-19
Amoéba S.A.. (8/19/19). "Press Release: Amoéba Informs that the EPA Cannot Grant the Registrations for the Use of Its Active Substance Willaertia magna C2c Maky in Cooling Towers". Lyon. 2019-08-19
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. 2019-08-19
Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. 2019-08-19
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-08-16
Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. 2019-08-16
Galapagos N.V.. (8/15/19). "Press Release: European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis". Foster City, CA & Mechelen. 2019-08-15
Tecan Group Ltd.. (8/15/19). "Press Release: H1 2019 – Tecan Again Posts Significant Increase in Sales, Driven by Strong Growth in the Life Sciences Business". Männedorf. 2019-08-15
Cerevel Therapeutics, LLC. (8/14/19). "Press Release: Cerevel Therapeutics Strengthens Leadership Team with the Appointment of Orly Mishan as Chief Business Officer". Boston, MA. 2019-08-14
Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. 2019-08-13
Quanterix Corporation. (8/13/19). "Press Release: Quanterix Announces Closing of Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares". Billerica, MA. 2019-08-13
iTeos Therapeutics S.A.. (8/13/19). "Press Release: iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer". Gosselies & Cambridge, MA. 2019-08-13
Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. 2019-08-13
908 Devices, Inc.. (8/12/19). "Press Release: 908 Devices Launches the Rebel, the First At-line Spent Cell Media Analyzer for Bioprocess Labs". Boston, MA. 2019-08-12
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
NRGene. (8/12/19). "Press Release: NRGene Announces Management and Business Updates". Ness Ziona & San Diego, CA. 2019-08-12
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. 2019-08-12
Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. 2019-08-12
Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. 2019-08-12
1 2 3 ... 119 120 121  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

» top